Laird Norton Wetherby Wealth Management
TSVT icon

Laird Norton Wetherby Wealth Management’s 2seventy bio TSVT Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-30,783
Closed -$288K – 947
2022
Q4 		$288K Buy
30,783
+13,893
+82% +$196K 0.02% 697
2022
Q3 		$246K Sell
16,890
-5,835
-26% -$86.6K 0.02% 733
2022
Q2 		$300K Buy
+22,725
New +$310K 0.02% 682

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's TSVT Position: Q1 2023 in Review

Laird Norton Wetherby Wealth Management sold out of 2seventy bio (TSVT) in Q1 2023, closing a stake of 30,783 shares — an estimated $288K sold.

Laird Norton Wetherby Wealth Management first reported a position in TSVT in Q2 2022 and held it in 3 quarters. The position peaked at $300K in Q2 2022. 147 funds tracked by Wall St. Rank hold TSVT as of Q1 2023.

  • Laird Norton Wetherby Wealth Management reported no remaining 2seventy bio position as of Q1 2023 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 30,783 2seventy bio shares in Q1 2023, an estimated $288K.
  • Laird Norton Wetherby Wealth Management first reported a position in 2seventy bio in Q2 2022 and held it in 3 quarters.
  • Laird Norton Wetherby Wealth Management's 2seventy bio position peaked at $300K in Q2 2022.
  • 147 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2023.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q1 2023, filed 12 May 2023.